Glutamatergic synapses in neurodevelopmental disorders
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Neurodevelopmental disorders (NDDs) are a group of diseases whose symptoms arise during childhood or adolescence and that impact several higher cognitive functions such as learning, sociability and mood. Accruing evidence suggests that a shared pathogenic mechanism underlying these diseases is the dysfunction of glutamatergic synapses. We summarize present knowledge on autism spectrum disorders (ASD), intellectual disability (ID), Down syndrome (DS), Rett syndrome (RS) and attention‐deficit hyperactivity disorder (ADHD), highlighting the involvement of glutamatergic synapses and receptors in these disorders. The most commonly shared defects involve &agr;‐amino‐3‐hydroxy‐5‐methyl‐ 4‐isoxazole propionic acid receptors (AMPARs), N‐methyl‐d‐aspartate receptors (NMDARs) and metabotropic glutamate receptors (mGluRs), whose functions are strongly linked to synaptic plasticity, affecting both cell‐autonomous features as well as circuit formation. Moreover, the major scaffolding proteins and, thus, the general structure of the synapse are often deregulated in neurodevelopmental disorders, which is not surprising considering their crucial role in the regulation of glutamate receptor positioning and functioning. This convergence of defects supports the definition of neurodevelopmental disorders as a continuum of pathological manifestations, suggesting that glutamatergic synapses could be a therapeutic target to ameliorate patient symptomatology. Graphical abstract Core mechanisms involved in the pathogenesis of NDDs. ASD (Autism Spectrum Disorder): Neurexin and neuroligins are transmembrane proteins localised in the pre‐ and post‐synaptic compartments, respectively that interact each other in the synaptic cleft. Mutations in the gene encoding Neurexin‐1, Neuroligin‐3 and 4 have been found in patients affected by ASD. Neurexins regulate presynaptic vesicles release whereas neuroligins, through the interaction with PSD‐95, affect NMDARs functioning. SHANK3 protein belongs to a class of scaffolding molecules and it is implicated in autistic phenotype in patients affected by Phelan McDermid syndrome. This protein regulates different glutamate receptors (NMDARs, AMPARs and mGluR5) through direct or indirect interactions mediated by PSD‐95, SAPAP and Homer. Moreover, IGF‐1 pathway has been found associated to Shank3‐depletion defects. Mutations on the NMDARs subunit encoding genes GRIN2A and GRIN2B, are also directly affected by mutations in ASDs patients. ID (Intellectual Disability): FMRP protein, encoded by FMR1 gene, which mutations cause Fragile X syndrome, regulates mRNA translation of a great variety of proteins with crucial functions in excitatory post‐synapses such as STEP, PSD‐95 and APP. mGluR5 is strongly implicated in the regulation of FMRP functioning, and vice versa. OPHN1 and TSPAN7, which encoding genes are found mutated in patients affected by ID, are involved in the regulation of AMPARs trafficking. The MAGUK protein CASK, also affected in ID patients, has functions in both the pre and post‐synaptic compartments. In the first case it regulates Voltage Gated Calcium Channels (VGCC) and Neurexins; in the second it is implicated in NMDARs trafficking similarly to SAP102, another protein which encoding gene has been found mutated in ID patients. The presynaptic proteins Synaptophysin (SYP) and Synapsin (SYN) are both strongly implicated in the release of presynaptic vesicles containing the neurotransmitter glutamate and mutations in their coding genes have been linked to ID. DS (Down Syndrome): In DS patients the triplication of Chromosome 21 leads to different defects. The gene encoding for APP is localized in Chr 21 and its overexpression results in an Alzheimer‐like dementia. Nine genes contained in the chromosome 21 encode for proteins that interact with NMDARs directly or through the Calcineurin/Calmodulin (CaN/CaM) system. Moreover, neuronal and glial alterations in metabotropic glutamate receptors have been identified. RS (Rett Syndrome): MeCP2 protein is an epigenetic modulator. Studies on its function have elucidated its regulatory effect on PSD‐95, which appears to be reduced upon MeCP2 loss of function, and on GluA1‐containing AMPARs, which instead are increased. mGluRs have also been involved in RS; in particular, mGluR5‐dependent LTD has been found impaired in Mecp2 knock‐out mice. ADHD (Attention‐deficit hyperactivity disorder): ADHD is probably the most complex of NDDs with very little knowledge on specific mechanisms involving glutamate. Nowadays, several mutations on genes encoding for NMDARs subunits, GRIN2A and GRIN2B, and for mGluRs, GRM1, GRM5, GRM7 and GRM8, have been linked to this pathology. Figure. No caption available. HighlightsGlutamatergic synapse defects are common features in ASD, ID, DS, RS and ADHD.Shared NDDs pathological mechanisms converge on NMDARs and mGluRs.Different NDDs could be treated with similar therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“Indeed, the amyloidprecursor protein (APP) is overexpressed in DS patients due to the presence of its encoding gene on human chromosome 21 (Kang et al., 1987).”
BackgroundGlutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 1×
“Furthermore, in an animal model of ADHD, such as dopamine transporter knock-out (DAT-KO) mice (Gainetdinov and Caron, 2000; Gainetdinov et al., 2001; Trinh et al., 2003), the positive modulation of AMPARs counteracted the hyperactivity phenotype, whereas NMDAR antagonists increased hyperactivity…”
BackgroundKESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 1×
“…that ADHD could persist into adulthood in 30–60% of cases, making this pathology highly subjected to comorbidities with several psychiatric disorders such as depression, anxiety and drug addiction (Kessler et al., 2005; Konstenius et al., 2012; McIntosh et al., 2009; Schatz and Rostain, 2006).”
BackgroundNMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851 · cited 1×
“(Etherton et al., 2011; Jamain et al., 2003; Talebizadeh et al., 2006) have been found in patients affected by autism spectrum disorder.”
BackgroundNeuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 2×
“DS patients, both in childhood and adulthood, present alterations in dendritic structure such as shorter dendrite length and reduced branching in the motor cortex, visual cortex, and hippocampal CA1 and CA3 regions (Suetsugu and Mehraein, 1980; Takashima et al., 1989, 1981).”
BackgroundMeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Structural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570 · cited 1×
“, 2016) or when the PDZ domain was removed (Mei et al., 2016; Peça et al., 2011; Zhou et al., 2016).”
BackgroundAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 1×
“mice, it was found to be exaggerated compared to that in wild type mice (Huber et al., 2002) which was consistent with the fact that both the”
ResultThe Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 2×
“This disease affects young girls (Chahrour and Zoghbi, 2007) with an onset between 6 and 18 months”
BackgroundSanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263
The Epidemiology of Autism Spectrum Disorders
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., Mandell, D. S., Miller, L. A., Pinto-Martin, J., Reaven, J., et al. (2007) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144007 · Cited by 1,228 · cited 1×
“exist in the reverse association, particularly for the syndromic forms of ID, such as FXS syndrome (Newschaffer et al., 2007).”
BackgroundCharacterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009 · cited 2×
“SHANK proteins play this role by indirectly interacting with NMDARs (Boeckers et al., 1999; Naisbitt et al., 1999), mGluRs (Tu et al., 1999) and AMPARs (Sheng and Kim, 2000; Uchino et al., 2006).”
BackgroundCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.-P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/382137 · Cited by 768
Rare de novo and transmitted copy-number variation in autistic spectrum disorders
Levy, D., Ronemus, M., Yamrom, B., Lee, Y.-H., Leotta, A., Kendall, J., Marks, S., Lakshmi, B., Pai, D., Ye, K., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.015 · Cited by 712 · cited 1×
“NLGN3, deletions (Levy et al., 2011; Sanders et al., 2011), and a single substitution mutation (R451C)”
Backgroundα-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis
Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K., & Südhof, T. C. (2003) · Nature · doi:10.1038/nature01755 · Cited by 699 · cited 1×
“Part of these defects may be related to a defective activity of voltage-dependent Ca2+ channels that in turn results in defective presynaptic vesicle release of neurotransmitters (Dudanova et al., 2006; Missler et al., 2003).”
BackgroundAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695 · cited 1×
“NMDAR function, normalized the transmission defects and ameliorated social interaction deficits (Won et al., 2012).”
BackgroundSHANK proteins: roles at the synapse and in autism spectrum disorder
Monteiro, P., & Feng, G. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.183 · Cited by 681
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · cited 1×
“This form of plasticity was shown to induce the translation of FMRP in synaptoneurosomes (Weiler et al., 1997).”
BackgroundLeblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., Mouzat, K., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004580 · Cited by 630
NIGG, J. T., & CASEY, B. J. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050376 · Cited by 593
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812394106 · Cited by 593 · cited 2×
“A study performed in Mecp2 KO mice showed immature and weaker synapses, as demonstrated by reduced PSD-95 expression and fewer synaptic contacts in the motor cortex as well as a reduction in the amplitude of sEPSCs recorded from layer 5 cortical neurons of the sensorimotor cortex (Tropea et al., 2009).”
BackgroundThe Shank family of scaffold proteins
Sheng, M., & Kim, E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1851 · Cited by 578
Arnsten, A. F. T., & Rubia, K. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.008 · Cited by 568
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563
Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711555105 · Cited by 556
Hata, Y., Butz, S., & Sudhof, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02488.1996 · Cited by 553
Salehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543
Cubillo, A., Halari, R., Smith, A., Taylor, E., & Rubia, K. (2012) · Cortex · doi:10.1016/j.cortex.2011.04.007 · Cited by 520 · cited 1×
“…in ADHD patients, glutamatergic transmission is altered in the prefrontal cortex and associated regions (Arnsten, 2009; Arnsten and Rubia, 2012; Cubillo et al., 2012; Moore et al., 2007, 2006; Prince, 2008; Vaidya and Stollstorff, 2008) and that psychostimulants, often used to treat this…”
BackgroundMeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489
Modeling Autism by SHANK Gene Mutations in Mice
Jiang, Y.-H., & Ehlers, M. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.016 · Cited by 488
Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
Phelan, K., & McDermid, H. E. (2011) · Molecular Syndromology · doi:10.1159/000334260 · Cited by 460
Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
Blundell, J., Blaiss, C. A., Etherton, M. R., Espinosa, F., Tabuchi, K., Walz, C., Bolliger, M. F., Südhof, T. C., & Powell, C. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4517-09.2010 · Cited by 450
Etherton, M. R., Blaiss, C. A., Powell, C. M., & Südhof, T. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910297106 · Cited by 447
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426
De Novo Mutations in Moderate or Severe Intellectual Disability
Hamdan, F. F., Srour, M., Capo-Chichi, J.-M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004772 · Cited by 419 · cited 1×
“to be associated with syndromic forms of ID (Hamdan et al., 2014; Hu et al., 2016; Marwick et al., 2015).”
BackgroundADHD With Comorbid Anxiety: A Review of the Current Literature
Schatz, D. B., & Rostain, A. L. (2006) · Journal of Attention Disorders · doi:10.1177/1087054706286698 · Cited by 407
Elia, J., Glessner, J. T., Wang, K., Takahashi, N., Shtir, C. J., Hadley, D., Sleiman, P. M. A., Zhang, H., Kim, C. E., Robison, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.1013 · Cited by 406
Adult restoration of Shank3 expression rescues selective autistic-like phenotypes
Mei, Y., Monteiro, P., Zhou, Y., Kim, J.-A., Gao, X., Fu, Z., & Feng, G. (2016) · Nature · doi:10.1038/nature16971 · Cited by 392
The top and the bottom of ADHD: a neuropsychological perspective
Sergeant, J. A., Geurts, H., Huijbregts, S., Scheres, A., & Oosterlaan, J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.004 · Cited by 372
Arnsten, A. F. T. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00005 · Cited by 371
Hsueh, Y.-P., Wang, T.-F., Yang, F.-C., & Sheng, M. (2000) · Nature · doi:10.1038/35005118 · Cited by 355
Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349
Zhou, Y., Kaiser, T., Monteiro, P., Zhang, X., Van der Goes, M. S., Wang, D., Barak, B., Zeng, M., Li, C., Lu, C., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.023 · Cited by 325
Down syndrome: Cognitive phenotype
Silverman, W. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20156 · Cited by 324
Autism-associated SHANK3 haploinsufficiency causes I h channelopathy in human neurons
Yi, F., Danko, T., Botelho, S. C., Patzke, C., Pak, C., Wernig, M., & Südhof, T. C. (2016) · Science · doi:10.1126/science.aaf2669 · Cited by 313
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Takashima, S., Becker, L. E., Armstrong, D. L., & Chan, F. (1981) · Brain Research · doi:10.1016/0006-8993(81)90314-0 · Cited by 307
Paradee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J., & Warren, S. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00285-7 · Cited by 305 · cited 1×
“However, the prominent forms of plasticity, the NMDAR-dependent LTP and LTD, were found unaltered in these animals (Godfraind et al., 1996; Huber et al., 2002; Paradee et al., 1999).”
BackgroundSynaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297
FMRP Mediates mGluR5-Dependent Translation of Amyloid Precursor Protein
Westmark, C. J., & Malter, J. S. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050052 · Cited by 296 · cited 3×
“1 (Waung et al., 2008), STEP (Goebel-Goody et al., 2012), APP (Westmark and Malter, 2007), PSD-95 and CAMKIIα (Ifrim et al., 2015; Muddashetty et al., 2007; Zalfa et al., 2003).”
BackgroundThe X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis
Govek, E.-E., Newey, S. E., Akerman, C. J., Cross, J. R., Van der Veken, L., & Van Aelst, L. (2004) · Nature Neuroscience · doi:10.1038/nn1210 · Cited by 293
Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons
Roussignol, G., Ango, F., Romorini, S., Tu, J. C., Sala, C., Worley, P. F., Bockaert, J., & Fagni, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4354-04.2005 · Cited by 293
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
Gauthier, J., Siddiqui, T. J., Huashan, P., Yokomaku, D., Hamdan, F. F., Champagne, N., Lapointe, M., Spiegelman, D., Noreau, A., Lafrenière, R. G., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0975-z · Cited by 286 · cited 2×
“NRXN1α is the gene that has been identified to be prominently involved in ASD, and NRXN2 has been found to be mutated in few patients affected by ASD or Schizophrenia (Gauthier et al., 2011).”
Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study
Marin‐Padilla, M. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670105 · Cited by 285
Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3
Meng, Y., Zhang, Y., & Jia, Z. (2003) · Neuron · doi:10.1016/s0896-6273(03)00368-4 · Cited by 251
Silverman, J. L., Smith, D. G., Rizzo, S. J. S., Karras, M. N., Turner, S. M., Tolu, S. S., Bryce, D. K., Smith, D. L., Fonseca, K., Ring, R. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003501 · Cited by 251
The emerging role of SHANK genes in neuropsychiatric disorders
Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22128 · Cited by 237
Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies
Grabrucker, A. M., Schmeisser, M. J., Schoen, M., & Boeckers, T. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.07.003 · Cited by 233
Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation
Grabrucker, A. M., Knight, M. J., Proepper, C., Bockmann, J., Joubert, M., Rowan, M., Nienhaus, G. U., Garner, C. C., Bowie, J. U., Kreutz, M. R., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.336 · Cited by 228
Carlesimo, G. A., Marotta, L., & Vicari, S. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00055-3 · Cited by 211
Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome
Bonaglia, M. C., Giorda, R., Mani, E., Aceti, G., Anderlid, B.-M., Baroncini, A., Pramparo, T., & Zuffardi, O. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.038604 · Cited by 211
Boeckers, T. M., Winter, C., Smalla, K.-H., Kreutz, M. R., Bockmann, J., Seidenbecher, C., Garner, C. C., & Gundelfinger, E. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1489 · Cited by 200
Suetsugu, M., & Mehraein, P. (1980) · Acta Neuropathologica · doi:10.1007/bf00688755 · Cited by 190
The neurobiological basis of ADHD
Curatolo, P., D'Agati, E., & Moavero, R. (2010) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-36-79 · Cited by 189 · cited 1×
“cortex, the corpus callosum and the cerebellum, in the pathophysiology of ADHD (Curatolo et al., 2010).”
BackgroundBianchi, P., Ciani, E., Guidi, S., Trazzi, S., Felice, D., Grossi, G., Fernandez, M., Giuliani, A., Calza, L., & Bartesaghi, R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0534-10.2010 · Cited by 188
Attention and executive functions profile in drug naive ADHD subtypes
Pasini, A., Paloscia, C., Alessandrelli, R., Porfirio, M. C., & Curatolo, P. (2007) · Brain and Development · doi:10.1016/j.braindev.2006.11.010 · Cited by 182 · cited 1×
“memory (Pasini et al., 2007; Sergeant et al., 2003), affective components, such as motivation and delay aversion (Castellanos et al.”
BackgroundBozdagi, O., Tavassoli, T., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-9 · Cited by 176
Amyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB
Lim, D., Iyer, A., Ronco, V., Grolla, A. A., Canonico, P. L., Aronica, E., & Genazzani, A. A. (2013) · Glia · doi:10.1002/glia.22502 · Cited by 169
Martı́nez-Cué, C., Baamonde, C., Lumbreras, M., Paz, J., Davisson, M. T., Schmidt, C., Dierssen, M., & Flórez, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00026-8 · Cited by 166
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
Bidinosti, M., Botta, P., Krüttner, S., Proenca, C. C., Stoehr, N., Bernhard, M., Fruh, I., Mueller, M., Bonenfant, D., Voshol, H., et al. (2016) · Science · doi:10.1126/science.aad5487 · Cited by 151
Rett Syndrome: Exploring the Autism Link
Percy, A. K. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.149 · Cited by 144
Naaijen, J., Bralten, J., Poelmans, G., The IMAGE consortium, Faraone, S., Asherson, P., Banaschewski, T., Buitelaar, J., Franke, B., P Ebstein, R., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.273 · Cited by 142
Etherton, M. R., Tabuchi, K., Sharma, M., Ko, J., & Südhof, T. C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.182 · Cited by 140
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
Schade, S., & Paulus, W. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv102 · Cited by 135
Ayberk Kurt, M., Ilker Kafa, M., Dierssen, M., & Ceri Davies, D. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.075 · Cited by 126
Trinh, J. V., Nehrenberg, D. L., Jacobsen, J. P. R., Caron, M. G., & Wetsel, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00165-9 · Cited by 113
Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD
Binder, C., McIntosh, Kutcher, S., Levitt, Rosenbluth, & Fallu (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4720 · Cited by 110
Vaidya, C. J., & Stollstorff, M. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.40 · Cited by 95
Uchino, S., Wada, H., Honda, S., Nakamura, Y., Ondo, Y., Uchiyama, T., Tsutsumi, M., Suzuki, E., Hirasawa, T., & Kohsaka, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03831.x · Cited by 95 · cited 1×
“SHANK proteins play this role by indirectly interacting with NMDARs (Boeckers et al., 1999; Naisbitt et al., 1999), mGluRs (Tu et al., 1999) and AMPARs (Sheng and Kim, 2000; Uchino et al., 2006).”
BackgroundPolarized targeting of neurexins to synapses is regulated by their C-terminal sequences
Fairless, R., Masius, H., Rohlmann, A., Heupel, K., Ahmad, M., Reissner, C., Dresbach, T., & Missler, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5294-07.2008 · Cited by 91
Deletion of α-neurexin II results in autism-related behaviors in mice
Dachtler, J., Glasper, J., Cohen, R. N., Ivorra, J. L., Swiffen, D. J., Jackson, A. J., Harte, M. K., Rodgers, R. J., & Clapcote, S. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.123 · Cited by 84 · cited 1×
“Nrxn2α knock-out mice also show impaired sociability and social memory (Dachtler et al., 2014).”
BackgroundIdentification of Tbr-1/CASK complex target genes in neurons
Wang, T., Ding, C., Wang, G., Luo, S., Lin, Y., Ruan, Y., Hevner, R., Rubenstein, J. L. R., & Hsueh, Y. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02845.x · Cited by 83
Li, W., Xu, X., & Pozzo-Miller, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517244113 · Cited by 80
Neurexin Dysfunction in Adult Neurons Results in Autistic-like Behavior in Mice
Rabaneda, L. G., Robles-Lanuza, E., Nieto-González, J. L., & Scholl, F. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.022 · Cited by 78
Su, T., Fan, H.-X., Jiang, T., Sun, W.-W., Den, W.-Y., Gao, M.-M., Chen, S.-Q., Zhao, Q.-H., & Yi, Y.-H. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2130-2 · Cited by 76 · cited 1×
“Neurexins are encoded by three genes: NRXN1, 2 and 3; each of them undergoes alternative splicing that produces α and β isoforms (Südhof, 2008).”
BackgroundKonstenius, M., Larsson, H., Lundholm, L., Philips, B., van de Glind, G., Jayaram-Lindström, N., & Franck, J. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712451126 · Cited by 54
Adults with Attention-Deficit/Hyperactivity Disorder ? A Brain Magnetic Resonance Spectroscopy Study
Dramsdahl, M., Ersland, L., Plessen, K. J., Haavik, J., Hugdahl, K., & Specht, K. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00065 · Cited by 43 · cited 1×
“adult ADHD patients shed new light on the reduced level of glutamate in the anterior cingulate cortex (Dramsdahl et al., 2011), supporting the”
Background
Cited by
Deneault, E., White, S. H., Rodrigues, D. C., Ross, P. J., Faheem, M., Zaslavsky, K., Wang, Z., Alexandrova, R., Pellecchia, G., Wei, W., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.003 · Cited by 145
“Importantly, differentiation of human iPSCs into forebrain glutamatergic neurons may lead to model systems that recapitulate early molecular events in the trajectory of ASD development (Habela et al., 2016; Moretto et al., 2018).”
BackgroundPan, W., Zhao, J., Wu, J., Xu, D., Meng, X., Jiang, P., Shi, H., Ge, X., Yang, X., Hu, M., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01471-8 · Cited by 113
Mohanan, A. G., Gunasekaran, S., Jacob, R. S., & Omkumar, R. V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.855752 · Cited by 55
Leithead, A. B., Tasker, J. G., & Harony‐Nicolas, H. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13061 · Cited by 26
Gene set enrichment analysis to create polygenic scores: a developmental examination of aggression
Elam, K. K., Clifford, S., Shaw, D. S., Wilson, M. N., & Lemery-Chalfant, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0513-7 · Cited by 23
Metadata
- Authors
- Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 84
- Issue
- Pt B
- Pages
- 328-342
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2754148882
- Cited by
- 136
- References
- 101
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.